Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 17 results:
Συντάκτης Τίτλος [ Τύπος(Desc)] Έτος
Φίλτρα: Συντάκτης is Lakis, Sotiris  [Clear All Filters]
Journal Article
Lakis, S., & Papamitsou T. (2010).  AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas. World Journal of Gastroenterology. 16(20), 2476.
Lakis, S., Papamitsou T., Panagiotopoulou C., Kotakidou R., & Kotoula V. (2010).  AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.. World J Gastroenterol. 16(20), 2476-83.
Lakis, S., Kotoula V., Eleftheraki A. G., Batistatou A., Bobos M., Koletsa T., et al. (2014).  The androgen receptor as a surrogate marker for molecular apocrine breast cancer subtyping.. Breast. 23(3), 234-43.
Dragoumis, D., Atmatzidis S., Chatzimavroudis G., Lakis S., Panagiotopoulou K., & Atmatzidis K. (2010).  Benign spindle cell tumor not otherwise specified (NOS) in a male breast.. Int J Surg Pathol. 18(6), 575-9.
Kotoula, V., Karavasilis V., Zagouri F., Kouvatseas G., Giannoulatou E., Gogas H., et al. (2016).  Effects of TP53 and PIK3CA mutations in early breast cancer: a matter of co-mutation and tumor-infiltrating lymphocytes.. Breast Cancer Res Treat. 158(2), 307-21.
Guibas, G. V., Lakis S., Gkimpas C., Manda M., Kapoukranidou D., & Spandou E. (2014).  Efficiency of different decalcification protocols for nasal osseous structures in a rat experimental model of allergic rhinitis, and their effects on epithelial histology: an attempt at standardization.. Exp Toxicol Pathol. 66(9-10), 469-75.
Kotoula, V., Lyberopoulou A., Papadopoulou K., Charalambous E., Alexopoulou Z., Gakou C., et al. (2015).  Evaluation of two highly-multiplexed custom panels for massively parallel semiconductor sequencing on paraffin DNA.. PLoS One. 10(6), e0128818.
Kotoula, V., Fostira F., Papadopoulou K., Apostolou P., Tsolaki E., Lazaridis G., et al. (2017).  The fate of BRCA1-related germline mutations in triple-negative breast tumors.. Am J Cancer Res. 7(1), 98-114.
Purrington, K. S., Visscher D. W., Wang C., Yannoukakos D., Hamann U., Nevanlinna H., et al. (2016).  Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.. Breast Cancer Res Treat. 157(1), 117-31.
Purrington, K. S., Slager S., Eccles D., Yannoukakos D., Fasching P. A., Miron P., et al. (2014).  Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.. Carcinogenesis. 35(5), 1012-9.
Levva, S., Kotoula V., Kostopoulos I., Manousou K., Papadimitriou C., Papadopoulou K., et al. (2017).  Prognostic Evaluation of Epidermal Growth Factor Receptor (EGFR) Genotype and Phenotype Parameters in Triple-negative Breast Cancers.. Cancer Genomics Proteomics. 14(3), 181-195.
Kamposioras, K., Konstantara A., Kotoula V., Lakis S., Kouvatseas G., Akriviadis E., et al. (2013).  The prognostic significance of WNT pathway in surgically-treated colorectal cancer: β-catenin expression predicts for disease-free survival.. Anticancer Res. 33(10), 4573-84.
Strati, T-M., Kotoula V., Kostopoulos I., Manousou K., Papadimitriou C., Lazaridis G., et al. (2017).  Prognostic Subcellular Notch2, Notch3 and Jagged1 Localization Patterns in Early Triple-negative Breast Cancer.. Anticancer Res. 37(5), 2323-2334.
Galanis, I., Dragoumis D., Kalogirou T., Lakis S., Kotakidou R., & Atmatzidis K. (2010).  Spontaneous perforation of solitary ulcer of transverse colon.. Indian J Pathol Microbiol. 53(1), 138-40.
Fountzilas, G., Giannoulatou E., Alexopoulou Z., Zagouri F., Timotheadou E., Papadopoulou K., et al. (2016).  TP53 mutations and protein immunopositivity may predict for poor outcome but also for trastuzumab benefit in patients with early breast cancer treated in the adjuvant setting.. Oncotarget. 7(22), 32731-53.
Kotoula, V., Lakis S., Vlachos I. S., Giannoulatou E., Zagouri F., Alexopoulou Z., et al. (2016).  Tumor Infiltrating Lymphocytes Affect the Outcome of Patients with Operable Triple-Negative Breast Cancer in Combination with Mutated Amino Acid Classes.. PLoS One. 11(9), e0163138.
Kotoula, V., Chatzopoulos K., Lakis S., Alexopoulou Z., Timotheadou E., Zagouri F., et al. (2016).  Tumors with high-density tumor infiltrating lymphocytes constitute a favorable entity in breast cancer: a pooled analysis of four prospective adjuvant trials.. Oncotarget. 7(4), 5074-87.

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.